Welcome to the InfoSci Platform
Evaluation of B2B Pharmaceutical Supply Chain in Australia

Evaluation of B2B Pharmaceutical Supply Chain in Australia

Chad Lin, Geoffrey Jalleh
Copyright: © 2015 |Pages: 24
ISBN13: 9781466681330|ISBN10: 1466681330|EISBN13: 9781466681347
DOI: 10.4018/978-1-4666-8133-0.ch003
Cite Chapter Cite Chapter

MLA

Lin, Chad, and Geoffrey Jalleh. "Evaluation of B2B Pharmaceutical Supply Chain in Australia." Strategic E-Commerce Systems and Tools for Competing in the Digital Marketplace, edited by Mehdi Khosrow-Pour, D.B.A., IGI Global, 2015, pp. 56-79. https://doi.org/10.4018/978-1-4666-8133-0.ch003

APA

Lin, C. & Jalleh, G. (2015). Evaluation of B2B Pharmaceutical Supply Chain in Australia. In M. Khosrow-Pour, D.B.A. (Ed.), Strategic E-Commerce Systems and Tools for Competing in the Digital Marketplace (pp. 56-79). IGI Global. https://doi.org/10.4018/978-1-4666-8133-0.ch003

Chicago

Lin, Chad, and Geoffrey Jalleh. "Evaluation of B2B Pharmaceutical Supply Chain in Australia." In Strategic E-Commerce Systems and Tools for Competing in the Digital Marketplace, edited by Mehdi Khosrow-Pour, D.B.A., 56-79. Hershey, PA: IGI Global, 2015. https://doi.org/10.4018/978-1-4666-8133-0.ch003

Export Reference

Mendeley
Favorite

Abstract

The pharmaceutical industry is one of the most innovative and research-intensive industries in the world. For example, five out of the top global Research and Development (R&D) companies were pharmaceutical companies. However, the industry is lagging behind other industries in adopting Business-to-Business (B2B) and supply chain technologies. With supply chain costs constituting around 25-40% of an organization's operating expenses, it is imperative for senior pharmaceutical executives to minimize this cost. Hence, the main objective of this chapter is to identify key B2B e-commerce management, evaluation, and benefits realization factors and challenges within the Australian pharmaceutical supply chain. The results of this study suggest that pharmaceutical companies not only need to carefully examine their B2B investment management and evaluation practices but also must invest in using appropriate evaluation methodologies for identifying and managing benefits, risks, and costs associated with their investments in B2B and supply chains.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.